We believe in the power of partnerships to advance innovation and drive improved health outcomes.

Our team of biotech specialists takes the time to listen and understand your specific needs. Then we collaborate with you to design an approach that meets those needs — efficiently and effectively moving your novel treatment along its development journey toward commercialization, and beyond.

  • When answers can’t come fast enough, when decisions will influence the ultimate value of your treatment, we embrace your mission as our own.
  • We will populate your trials with qualified patients, generating the detailed data needed for approvals.
  • We will help you define and understand your treatment’s full potential in a competitive world.


Biopharmaceutical development capabilities.


Personal attention with a global reach.

In 2022, Fortrea helped to develop 100 percent of the oncology drugs approved by the FDA. We were also pivotal in the development of 92 percent of all drugs approved by the FDA and helped develop drugs in over 100 countries. That's the proven track record we can bring to your project.

Fortrea will work as a seamless extension of your team to support any — or every — phase of drug development to optimize your product’s value and patent life. By sharing our global therapeutic, scientific and regulatory expertise, we can help you bring new, life-changing options forward for healthcare providers and their patients.

Stay up to date:
Subscribe for Fortrea news & announcements.